Envelope fusion protein binding studies in an inducible model of retrovirus receptor expression and in CD34+ cells emphasize limited transduction at low receptor levels
- 1 April 2001
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (8) , 593-599
- https://doi.org/10.1038/sj.gt.3301438
Abstract
Successful gene therapy for the treatment of heritable or acquired diseases typically requires high efficiency gene transfer and sustained transgene expression. Indirect evidence on the basis of RNA analysis and in vivo competitive repopulation experiments in animal models suggests a correlation between transduction efficiency and the abundance of retrovirus receptors on the hematopoietic target cell. However, transduction by oncoretroviral vectors is also subject to other factors such as target cell cycle status and the composition of the virus-containing medium, making it difficult to determine the level of receptor expression required for efficient transduction. In the present study we investigated the impact of receptor expression level on transduction by a vector with a gibbon ape leukemia virus (GALV) envelope protein in a tetracycline-inducible tissue culture model that allowed for the cell cycle-independent, regulated expression of the GALV receptor (Pit1) in otherwise non-susceptible NIH 3T3 cells. Up-regulation of receptor RNA expression by 4.5-fold resulted in a mean 150-fold increase in transduction efficiency. We then analyzed cell surface expression of the Pit1 receptor using a fusion protein consisting of GALV SU portion of the viral envelope protein linked to the human IgG Fc. These experiments showed that tetracycline-regulated receptor induction resulted in a dose-dependent increase in binding of fusion protein. At maximum induction fusion protein binding increased up to five-fold which paralleled the increase in RNA expression, and correlated with the improved transduction efficiency. Finally, studies of pseudotype-specific fusion protein binding to human CD34-enriched cells revealed increased expression of retrovirus receptors after cytokine stimulation, although overall receptor expression in CD34+cells remained lower than in fibroblast cell lines efficiently transduced by amphotropic and GALV vectors.Keywords
This publication has 16 references indexed in Scilit:
- Effect of Changes in Expression of the Amphotropic Retroviral Receptor PiT-2 on Transduction Efficiency and Viral Titer: Implications for Gene TherapyHuman Gene Therapy, 2000
- Cell-surface receptors for retroviruses and implications for gene transfer.Proceedings of the National Academy of Sciences, 1996
- The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction.Proceedings of the National Academy of Sciences, 1996
- High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.Proceedings of the National Academy of Sciences, 1995
- Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters.Proceedings of the National Academy of Sciences, 1994
- Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus.Proceedings of the National Academy of Sciences, 1994
- Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elementsTrends in Biochemical Sciences, 1993
- Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proceedings of the National Academy of Sciences, 1992
- l-Histidinol Provides Effective Selection of Retrovirus-Vector-Transduced Keratinocytes Without Impairing Their Proliferative PotentialHuman Gene Therapy, 1991
- Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.Molecular and Cellular Biology, 1990